Redmile Group, LLC - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 142 filers reported holding BLUEPRINT MEDICINES CORP in Q3 2017. The put-call ratio across all filers is 0.76 and the average weighting 0.5%.

Quarter-by-quarter ownership
Redmile Group, LLC ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q2 2017$18,623,000
+16.4%
367,537
-8.1%
1.13%
+9.2%
Q1 2017$15,996,000
+1855.5%
400,000
+1352.5%
1.04%
+1496.9%
Q3 2016$818,000
+42.5%
27,539
-2.9%
0.06%
+18.2%
Q2 2016$574,000
+17.6%
28,353
+4.8%
0.06%
+10.0%
Q1 2016$488,000
-93.3%
27,055
-90.2%
0.05%
-90.8%
Q4 2015$7,288,000
-7.1%
276,687
-24.7%
0.54%
-8.2%
Q3 2015$7,842,000
-18.9%
367,485
-2.8%
0.59%
-25.1%
Q2 2015$9,671,000378,2350.79%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q3 2017
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 581,768$25,487,2569.57%
Casdin Capital, LLC 1,477,800$64,742,4185.02%
Nextech Invest Ltd. 188,228$8,246,2693.28%
DAFNA Capital Management LLC 261,235$11,444,7053.22%
Rock Springs Capital Management LP 1,891,510$82,867,0531.99%
HealthCor Management, L.P. 30,000$1,314,3001.20%
EFG Asset Management (North America) Corp. 110,853$4,766,6791.07%
Novo Holdings A/S 370,000$16,209,7001.01%
SECTORAL ASSET MANAGEMENT INC 115,900$5,077,5790.98%
EMERALD MUTUAL FUND ADVISERS TRUST 305,709$13,393,1110.83%
View complete list of BLUEPRINT MEDICINES CORP shareholders